WuXi AppTec, one of the biggest biotech employers in Philadelphia, is facing intense scrutiny from the U.S. government, pushing local companies to seek alternatives.
WuXi AppTec is building a 1.7 million-square-foot biotech contract manufacturing plant in Middletown, Del., with $22 million in state aid. At the same time, Congress is proposing to ban cell and gene therapy developers and others that do business with the China-based firm from receiving federal cash.For more than a decade, Chinese biotech pioneers WuXi AppTec and BGI Group, their spin-offs and affiliates, have forged close scientific and financial relationships developed by U.S.
He’s worried that other American, Asian, and European biotech companies won’t have the immediate capital, labor and know-how to “pick up the slack” if Congress goes through with its ban in an industry where novel therapies remain dependent on early federal support.Likewise, Kevin Mahoney, chief executive at the University of Pennsylvania Health System, whose researchers include leaders in gene and cell therapies, said: “We need low-cost start-up manufacturing to grow these businesses here.
Gu added that the company had earned its reputation as “a trusted partner” and said the company is concerned the bill could damage American leadership in biotech and delay medicine “to those in need.” In 2011, Children’s Hospital of Philadelphia announced a 10-year deal with BGI, then known as Beijing Genomics Institute, to sequence cells for research projects. That deal was “terminated” effective May 2018, according to CHOP.
Spark’s new building on Chestnut Street near its 30th Street labs “is planned for manufacturing only for Spark, and the Roche network,” said Spark spokesperson Allie Long.Over the years, Penn has debated emulating the University of Massachusetts and other schools by setting up a regional biotech manufacturing facility, possibly at the Pennovation complex in South Philly. It would be a place commercial companies could use, making it easier to lure and grow more successful biotech companies.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Experts Tell Congress: China Building ‘World’s Largest DNA Database’ Usable to Harvest OrgansSource of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and conservative thinkers.
Baca lebih lajut »
TikTok aside, Congress has its eye on the U.S. money going into ChinaGreater Congressional scrutiny on U.S. investments into China means any new rules or restrictions may outlast presidential terms and become part of U.S. law.
Baca lebih lajut »
Congress’ China Obsession Obscures TikTok’s Larger DangersJohanna Costigan is a writer and editor from New York. She writes about China’s digital governance, contested memory, and heterogeneous publics. Her articles and opinion pieces have been featured in Foreign Policy, Rest of World, The Diplomat, The China Project, Nikkei Asia, MERICS, the Los Angeles Review of Books China Channel, and other outlets.
Baca lebih lajut »
The auto industry’s Congress member is worried about losing the EV race to ChinaIn an interview with The Verge, Rep. Debbie Dingell (D-MI) talks about the need to shift to electric vehicles, competition from China, and why Republicans oppose electrification.
Baca lebih lajut »
Experts to Congress: China Is Hijacking Key U.N. Agencies to Advance Communist AgendaSource of breaking news and analysis, insightful commentary and original reporting, curated and written specifically for the new generation of independent and conservative thinkers.
Baca lebih lajut »
Pentagon two weeks from decision on China-focused joint military task force sought by CongressThe Pentagon is close to completing an assessment into setting up a congressionally mandated joint military force for the Pacific that lawmakers say is needed to prepare for war with China, Defense Secretary Lloyd Austin told Congress this week.
Baca lebih lajut »